# Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

> **NCT00490009** · PHASE2 · COMPLETED · sponsor: **Susan Knox** · enrollment: 9 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Bexxar
- **DRUG:** Acetaminophen
- **DRUG:** Diphenhydramine
- **DRUG:** Potassium Iodide (KI)

## Key facts

- **NCT ID:** NCT00490009
- **Lead sponsor:** Susan Knox
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2010-04
- **Final completion:** 2013-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490009, "Phase 2 Study of Bexxar in Relapsed/Refractory DLCL". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00490009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*